# Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

> **NCT00485433** · PHASE2 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 98 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine HCl
- **DRUG:** SKY0402

## Key facts

- **NCT ID:** NCT00485433
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-12
- **Final completion:** 2008-08
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00485433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00485433, "Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00485433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*